Xtx Topco LTD Volitionrx LTD Transaction History

Xtx Topco LTD

$1.72 Billion
Q3 2025

A detailed history of Xtx Topco LTD transactions in Volitionrx LTD stock. As of the latest transaction made, Xtx Topco LTD holds 35,682 shares of VNRX stock, worth $11,775. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,682

Holding current value

$11,775

% of portfolio

0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$0.6 - $0.78 $21,409 - $27,831	35,682 New	35,682 $24,000
Q1 2025 May 07, 2025	BUY	$0.51 - $0.67 $5,564 - $7,310	10,911 Added 51.08%	32,270 $18,000
Q4 2024 Feb 13, 2025	BUY	$0.56 - $0.88 $11,961 - $18,795	21,359 New	21,359 $12,000

Others Institutions Holding VNRX

# of Institutions

Shares Held

26.3M

Call Options Held

Put Options Held

Lagoda Investment Management, L.P. New York, NY

12.5M
Shares

$4.12 Million
4.96% of portfolio
Armistice Capital, LLC New York, NY

9.38M
Shares

$3.1 Million
0.1% of portfolio
Vanguard Group Inc Valley Forge, PA

1.53M
Shares

$504,915
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

878K
Shares

$289,796
0.0% of portfolio
Black Rock Inc. New York, NY

516K
Shares

$170,304
0.0% of portfolio

View Full List

About VOLITIONRX LTD

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $18.9M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

More about VNRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account